Zentalis Pharmaceuticals, Inc.(ZNTL)

Biotechnology · San Diego, CA

$2.67-0.11 (-3.96%)

Delayed quote: Oct 6, 2026, 4:00 PM EDT

Earnings Yield: N/A

Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.

The earnings yield is N/A as of 2026-10-06T22:43:52.364Z.

Stored calculation inputs

Calculation as of: 2026-10-06T22:43:52.364Z.

Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.

Unrounded diluted TTM EPS · period ending 2026-06-30: -2.46
Quote price: 2.67

FMP input reference: e5b22bec38318fdeba07533daebf1876a752163d7d28918210f347f826af404f

P/E Ratio|FCF Yield|Dividend Yield|All Metrics

ZNTL Earnings Yield Metrics

EARNINGS YIELD

N/A

ZNTL Competitors' Earnings Yield

ZNTL

Zentalis Pharmaceuticals, Inc.

Current

Market Cap

$190.07M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ELDN

Eledon Pharmaceuticals, Inc.

vs ZNTL

Market Cap

$189.11M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

RXST

RxSight, Inc.

vs ZNTL

Market Cap

$192.49M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

SRZN

Surrozen, Inc.

vs ZNTL

Market Cap

$197.18M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ANTX

AN2 Therapeutics, Inc.

vs ZNTL

Market Cap

$182.60M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

XGN

Exagen Inc.

vs ZNTL

Market Cap

$197.87M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

RNAC

Cartesian Therapeutics, Inc.

vs ZNTL

Market Cap

$198.33M

Earnings Yield

N/A

TTM Avg

19.04%

3Y Avg

19.04%

5Y Avg

19.04%

CNTN

Canton Strategic Holdings Inc

vs ZNTL

Market Cap

$180.47M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CMPX

Compass Therapeutics, Inc.

vs ZNTL

Market Cap

$179.75M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ORMP

Oramed Pharmaceuticals Inc.

vs ZNTL

Market Cap

$179.26M

Earnings Yield

93.84%

TTM Avg

50.31%

3Y Avg

28.59%

5Y Avg

28.59%

NAME	MARKET CAP	EARNINGS YIELD	TTM	3Y	5Y
Zentalis Pharmaceuticals, Inc. (ZNTL)	$190.07M	N/A	N/A	N/A	N/A
Eledon Pharmaceuticals, Inc. (ELDN)vs ›	$189.11M	N/A	N/A	N/A	N/A
RxSight, Inc. (RXST)vs ›	$192.49M	N/A	N/A	N/A	N/A
Surrozen, Inc. (SRZN)vs ›	$197.18M	N/A	N/A	N/A	N/A
AN2 Therapeutics, Inc. (ANTX)vs ›	$182.60M	N/A	N/A	N/A	N/A
Exagen Inc. (XGN)vs ›	$197.87M	N/A	N/A	N/A	N/A
Cartesian Therapeutics, Inc. (RNAC)vs ›	$198.33M	N/A	19.04%	19.04%	19.04%
Canton Strategic Holdings Inc (CNTN)vs ›	$180.47M	N/A	N/A	N/A	N/A
Compass Therapeutics, Inc. (CMPX)vs ›	$179.75M	N/A	N/A	N/A	N/A
Oramed Pharmaceuticals Inc. (ORMP)vs ›	$179.26M	93.84%	50.31%	28.59%	28.59%

Earnings Yield vs P/E Ratio

Earnings Yield

N/A

EPS ÷ Price

P/E Ratio

N/A

Price ÷ EPS

Formula: Earnings Yield = (EPS / Price) × 100

Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.

How earnings yield is used:

It expresses earnings relative to share price as a percentage
It can be compared with FCF yield and dividend yield
It can be compared with bond yields because both are percentages
It is mathematically the inverse of the P/E ratio

Earnings Yield Formula & Definition

Earnings Yield = EPS (TTM) / Share Price

Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Earnings Yield: N/A

ZNTL Earnings Yield Metrics

ZNTL Competitors' Earnings Yield

Earnings Yield vs P/E Ratio

Earnings Yield Formula & Definition

Related Metrics